GEN Exclusives

More »

Tutorials

More »

For full access to this article login to GEN Select now.

Apr 15, 2014 (Vol. 34, No. 8)

Improving HCP Impurity Assessment

  • Large molecule, protein-based biopharmaceuticals can have significant advantages over conventional small molecule pharmaceuticals including greater specificity, lower toxicity, and higher efficacy. Despite their potential ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Alzheimer's Therapies

Do you think an effective treatment for Alzheimer’s will be found within the next 10–15 years?